These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12007646)

  • 1. Type 1 and type 2 responses to Leishmania major.
    Rogers KA; DeKrey GK; Mbow ML; Gillespie RD; Brodskyn CI; Titus RG
    FEMS Microbiol Lett; 2002 Mar; 209(1):1-7. PubMed ID: 12007646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection.
    Gomes R; Oliveira F; Teixeira C; Meneses C; Gilmore DC; Elnaiem DE; Kamhawi S; Valenzuela JG
    J Invest Dermatol; 2012 Dec; 132(12):2735-43. PubMed ID: 22739793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease.
    Oliveira F; Lawyer PG; Kamhawi S; Valenzuela JG
    PLoS Negl Trop Dis; 2008 Apr; 2(4):e226. PubMed ID: 18414648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.
    Abi Abdallah DS; Pavinski Bitar A; Oliveira F; Meneses C; Park JJ; Mendez S; Kamhawi S; Valenzuela JG; Marquis H
    Infect Immun; 2014 Jul; 82(7):2736-45. PubMed ID: 24733091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.
    Wheat WH; Arthun EN; Spencer JS; Regan DP; Titus RG; Dow SW
    Vaccine; 2017 Dec; 35(48 Pt B):6611-6619. PubMed ID: 29079105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.
    Valenzuela JG; Belkaid Y; Garfield MK; Mendez S; Kamhawi S; Rowton ED; Sacks DL; Ribeiro JM
    J Exp Med; 2001 Aug; 194(3):331-42. PubMed ID: 11489952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
    Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection.
    Martin-Martin I; Chagas AC; Guimaraes-Costa AB; Amo L; Oliveira F; Moore IN; DeSouza-Vieira TS; Sanchez EE; Suntravat M; Valenzuela JG; Ribeiro JMC; Calvo E
    PLoS Pathog; 2018 May; 14(5):e1007006. PubMed ID: 29723281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
    Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
    Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers home in on leishmaniasis vaccine.
    Am J Vet Res; 2001 Oct; 62(10):1517. PubMed ID: 11592312
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of susceptibility and resistance to Leishmania major in mice.
    Sacks D; Noben-Trauth N
    Nat Rev Immunol; 2002 Nov; 2(11):845-58. PubMed ID: 12415308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.
    Kammoun-Rebai W; Bahi-Jaber N; Naouar I; Toumi A; Ben Salah A; Louzir H; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005905. PubMed ID: 29023574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and perspectives in vaccination against leishmaniasis.
    de Oliveira CI; Nascimento IP; Barral A; Soto M; Barral-Netto M
    Parasitol Int; 2009 Dec; 58(4):319-24. PubMed ID: 19698801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection.
    Xu X; Oliveira F; Chang BW; Collin N; Gomes R; Teixeira C; Reynoso D; My Pham V; Elnaiem DE; Kamhawi S; Ribeiro JM; Valenzuela JG; Andersen JF
    J Biol Chem; 2011 Sep; 286(37):32383-93. PubMed ID: 21795673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.